FDA Approved: RIZATRIPTAN BENZOATE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approves Rizatriptan benzoate Original Application (ANDA) from Teva as a generic rizatriptan benzoate product for acute treatment of migraine. This marks th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Rizatriptan Benzoate (rizatriptan benzoate)

Snippet

ORIG AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)